Genes and Diseases (Sep 2023)
Inhibition of lysine-specific demethylase 1 (LSD1) prevented tumor growth and metastasis by downregulating PD-L1 expression in lung adenocarcinoma
- Pengxing He,
- Linna Du,
- Pan Hao,
- Han Yang,
- Yufei Ren,
- Huiqin Kang,
- Yanli Ding,
- Wen Zhao,
- Yichao Xu,
- Hongmin Liu
Affiliations
- Pengxing He
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan 450001, China
- Linna Du
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China
- Pan Hao
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China
- Han Yang
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China
- Yufei Ren
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China
- Huiqin Kang
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China
- Yanli Ding
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China
- Wen Zhao
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China
- Yichao Xu
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan 450001, China; Corresponding author. Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.
- Hongmin Liu
- Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Institute of Drug Discovery & Development, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China; State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan 450001, China; Corresponding author. State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan 450001, China.
- Journal volume & issue
-
Vol. 10,
no. 5
pp. 1779 – 1782